It’s time to take psilocybin seriously as a possible treatment for substance use disorders
The American Journal of Drug and Alcohol Abuse – August 24, 2016
Source: OpenAlex
Summary
An exciting development in Psychiatry shows psilocybin, a powerful hallucinogen, significantly aids substance abuse treatment. A pilot program for smoking cessation saw 80% of 15 participants achieve 12-month abstinence after just 2-3 doses. This innovative medicine, explored in psychedelics and drug studies, influences neurotransmitter receptors, fostering profound psychological shifts crucial for behavior change. Derived from chemical synthesis and alkaloids, this approach offers new hope for addressing substance use challenges, representing a fascinating intersection of Psychology and modern medicine.
Abstract
In the current issue of the American Journal of Drug and Alcohol Abuse, Johnson et al. (1) provide long-term outcome data from a smoking cessation pilot study of a treatment model using 2–3 doses o...